AstraZeneca PLC Notice of AGM (6757Z)
March 16 2017 - 6:00AM
UK Regulatory
TIDMAZN
RNS Number : 6757Z
AstraZeneca PLC
16 March 2017
16 March 2017 11:00 GMT
NOTICE OF ANNUAL GENERAL MEETING
AstraZeneca PLC (the Company) announced today the publication of
its Notice of Annual General Meeting 2017 and Shareholders'
Circular, together with a covering letter from the Chairman.
Copies of the documents have been submitted to the National
Storage Mechanism and will shortly be available for inspection at
www.morningstar.co.uk/uk/nsm. The documents are also available on
the Company's website at www.astrazeneca.com/agm.
The Company's Annual Report and Form 20-F Information 2016 was
published on 7 March 2017.
The above documents are being despatched to shareholders
today.
The meeting place for the Annual General Meeting (AGM) will be
the Park Plaza London Riverbank Hotel, 18 Albert Embankment, London
SE1 7TJ and the AGM will commence at 2.30 pm (BST) on 27 April
2017.
A C N Kemp
Company Secretary
About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company
that focuses on the discovery, development and commercialisation of
prescription medicines, primarily for the treatment of diseases in
three main therapy areas - Oncology, Cardiovascular & Metabolic
Diseases and Respiratory. The Company also is selectively active in
the areas of Autoimmunity, Neuroscience and Infection. AstraZeneca
operates in over 100 countries and its innovative medicines are
used by millions of patients worldwide. For more information,
please visit www.astrazeneca.com and follow us on Twitter
@AstraZeneca.
Media Enquiries
Esra Erkal-Paler UK/Global +44 203 749 5638
Vanessa Rhodes UK/Global +44 203 749 5736
Karen Birmingham UK/Global +44 203 749 5634
Rob Skelding UK/Global +44 203 749 5821
Jacob Lund Sweden +46 8 553 260 20
Michele Meixell US +1 302 885 2677
Investor Relations
Thomas Kudsk Larsen +44 203 749 5712
Craig Marks Finance, Fixed Income, M&A +44 7881 615 764
Henry Wheeler Oncology +44 203 749 5797
Mitchell Chan Oncology +1 240 477 3771
Lindsey Trickett Cardiovascular & Metabolic Diseases +1 240 543 7970
Nick Stone Respiratory +44 203 749 5716
Christer Gruvris Autoimmunity, Neuroscience & Infection +44 203 749 5711
US toll free +1 866 381 7277
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOAGGUQUWUPMGUQ
(END) Dow Jones Newswires
March 16, 2017 07:00 ET (11:00 GMT)
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Apr 2024 to May 2024
Astrazeneca (LSE:AZN)
Historical Stock Chart
From May 2023 to May 2024
